Heneka studied medicine at the University of Tübingen and received clinical training in Neurology at several universities. From 2016 to 2021, he directed neurodegenerative disease research at the University Hospital Bonn and the DZNE. Since January 2022, he has been the Director of the Luxembourg Centre for Systems Biomedicine (LCSB) at the University of Luxembourg. Additionally, he serves as an adjunct professor at the University of Massachusetts Chan Medical School. Heneka has received prestigious awards for his Alzheimer’s and ALS research.
Prof. Michael Heneka